Dashboard
1
Poor Management Efficiency with a low ROCE of 3.21%
- The company has been able to generate a Return on Capital Employed (avg) of 3.21% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of 5.90% and Operating profit at -43.56% over the last 5 years
3
Positive results in Mar 25
4
With ROE of 3.26%, it has a expensive valuation with a 1.50 Price to Book Value
5
Market Beating performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
CNY 1,484 Million (Small Cap)
46.00
NA
0.23%
-0.28
3.26%
1.50
Revenue and Profits:
Net Sales:
131 Million
(Quarterly Results - Jun 2025)
Net Profit:
14 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.76%
0%
1.76%
6 Months
47.41%
0%
47.41%
1 Year
49.48%
0%
49.48%
2 Years
72.76%
0%
72.76%
3 Years
54.59%
0%
54.59%
4 Years
1.54%
0%
1.54%
5 Years
0%
0%
0.0%
Inno Laser Technology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
5.90%
EBIT Growth (5y)
-43.56%
EBIT to Interest (avg)
-2.50
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
0.38
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
69.20%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.21%
ROE (avg)
3.60%
Valuation key factors
Factor
Value
P/E Ratio
46
Industry P/E
Price to Book Value
1.50
EV to EBIT
187.84
EV to EBITDA
25.16
EV to Capital Employed
1.69
EV to Sales
2.59
PEG Ratio
0.08
Dividend Yield
0.23%
ROCE (Latest)
0.90%
ROE (Latest)
3.26%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
131.20
113.00
16.11%
Operating Profit (PBDIT) excl Other Income
16.50
8.10
103.70%
Interest
0.20
0.20
Exceptional Items
0.00
0.20
-100.00%
Consolidate Net Profit
14.40
6.90
108.70%
Operating Profit Margin (Excl OI)
51.50%
-18.30%
6.98%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 16.11% vs 51.47% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 108.70% vs 7,000.00% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
441.70
363.70
21.45%
Operating Profit (PBDIT) excl Other Income
31.60
-3.70
954.05%
Interest
1.10
0.60
83.33%
Exceptional Items
0.10
0.20
-50.00%
Consolidate Net Profit
17.80
-5.30
435.85%
Operating Profit Margin (Excl OI)
-24.60%
-95.60%
7.10%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 21.45% vs 15.02% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 435.85% vs -122.18% in Dec 2023
About Inno Laser Technology Co., Ltd. 
Inno Laser Technology Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






